Announcement
10 Oct 2023
In August 2023, US BARDA awarded a contract to Venatorx Pharmaceuticals to support the development of a new oral antibiotics to combat drug-resistant bacterial infections.
Source
Sign in to access
Number of interventions
1
1 certainly harmful
0 likely harmful
0 liberalising
List of interventions
1 in force
Implementation date
10 Oct 2023
Revocation date:
No revocation date
State aid, unspecified
In force
On 10 October 2023, the Biomedical Advanced Research and Development Authority (BARDA) of the United States announced awarding Venatorx Pharmaceuticals a contract to support the development of an oral...
Sign in to see more
Threads
See all
This state act is not part of any Thread yet.